Bright Horizons Family Solutions header image

Bright Horizons Family Solutions

BFAM

Equity

ISIN US1091941005 / Valor 19920287

New York Stock Exchange, Inc (2024-09-17)
USD 138.30-1.21%

Bright Horizons Family Solutions
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Bright Horizons Family Solutions is a leading provider of employer-sponsored child care, early education, and work/life solutions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (14.08.2024):

Revenue Growth

Bright Horizons Family Solutions reported a revenue of $623 million for the first quarter of 2024, marking a 12% increase compared to the first quarter of 2023. This growth was driven by enrollment gains, tuition price increases at their centers, and increased utilization of back-up care services.

Income from Operations

Income from operations for Bright Horizons Family Solutions in the first quarter of 2024 was $40 million, a 30% increase from the $30.6 million reported in the first quarter of 2023. This rise was primarily due to higher gross profit contributions from the full service center-based child care segment and increased utilization of back-up care services.

Net Income and Earnings Per Share

Bright Horizons Family Solutions achieved a net income of $17 million for the first quarter of 2024, a significant 109% increase from the $8.1 million reported in the same period of the previous year. Diluted earnings per common share also saw a substantial rise, reaching $0.29 compared to $0.14 in the first quarter of 2023.

Adjusted EBITDA

In the first quarter of 2024, Bright Horizons Family Solutions reported an adjusted EBITDA of $75 million, which represents a 7% increase from the first quarter of 2023. This improvement was mainly due to the increase in gross profit in the full service center-based child care segment.

2024 Financial Outlook

Bright Horizons Family Solutions has provided a positive outlook for fiscal year 2024, expecting revenue to be in the range of $2.6 billion to $2.7 billion. Additionally, the company anticipates diluted adjusted earnings per common share to be between $3.00 and $3.20, reflecting their confidence in continued growth and strong performance.

Summarized from source with an LLMView Source

Key figures

57.8%1Y
-4.30%3Y
-13.2%5Y

Performance

33.1%1Y
37.6%3Y
43.3%5Y

Volatility

Market cap

7928 M

Market cap (USD)

Daily traded volume (Shares)

60,193

Daily traded volume (Shares)

1 day high/low

140.87 / 138.25

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

FibroGen Inc
FibroGen Inc FibroGen Inc Valor: 25953994
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.91%USD 0.45
AtriCure Inc
AtriCure Inc AtriCure Inc Valor: 2134051
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.82%USD 28.07
Galenica Ltd.
Galenica Ltd. Galenica Ltd. Valor: 36067446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.88%CHF 72.90
Idorsia Ltd
Idorsia Ltd Idorsia Ltd Valor: 36346343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.61%CHF 1.52
Syndax Pharmaceuticals Inc
Syndax Pharmaceuticals Inc Syndax Pharmaceuticals Inc Valor: 24112479
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.77%USD 18.06
Ypsomed Holding AG
Ypsomed Holding AG Ypsomed Holding AG Valor: 1939699
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.95%CHF 417.50
Ironwood Pharmaceuticals Inc
Ironwood Pharmaceuticals Inc Ironwood Pharmaceuticals Inc Valor: 10773079
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.22%USD 4.48
Udemy Inc
Udemy Inc Udemy Inc Valor: 114176816
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.37%USD 8.04
Arvinas Inc
Arvinas Inc Arvinas Inc Valor: 43526042
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.68%USD 25.32
Medacta Group Ltd
Medacta Group Ltd Medacta Group Ltd Valor: 46852522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.65%CHF 122.40